Home > Insider Trading > Filing (0001127602-20-021823)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
310158	Merck & Co. Inc.	MRK	Pharmaceutical Preparations (2834)	221918501

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1628884	L. Julie Gerberding	Merck &Amp; Co., Inc. 2000 Galloping Hill Road Kenilworth NJ 07033	Evp Strat Comm, Gi Pub Policy	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-07-17	18,111	$0.00	62,862	No	4	M	Direct
Common Stock	Disposition	2020-07-17	18,111	$80.00	44,751	No	4	S	Direct
Common Stock	Disposition	2020-07-17	18,174	$80.01	26,577	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-07-17	18,111	$0.00	18,111	$54.68

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2017-05-10	2026-05-09	No	4	M	Direct

Footnotes

The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.0000 to $80.0450, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
Holdings include shares acquired in dividend reinvestment transactions.
The option became exercisable in equal installments on 5/10/2017, 5/10/2018 and 5/10/2019.